Glaxo's swine flu vax effective in single dose; Xoma inks $25M Lucentis royalty deal;

> GlaxoSmithKline joins a lineup of big vaccine makers reporting that a single shot of its new swine flu vaccine is demonstrating a strong immune response in clinical trials. A single-dose approach to the pandemic has the potential to significantly boost the number of people vaccinated against the new flu. Report

> Xoma's shares jumped after the biotech company said it would pay off a loan to Goldman Sachs Specialty Holdings by handing the royalty rights to Lucentis to Genentech. Xoma gets a $25 million payment. Report

> Almac Diagnostics has inked a deal with Lilly UK to develop a companion diagnostic test for a combo lung cancer drug. Story

> An independent monitoring committee is recommending the continuation of GTx's late-stage trial of its prostate cancer therapy toremifene. Release

> The FDA has approved GenSpera's clinical trials of its cancer drug G-202. Report

Pharma News

> The Senate healthcare plan championed by Sen. Max Baucus is about to get a boost from pharma. The industry trade group PhRMA is prepping a series of TV ads that specifically support Baucus's version of healthcare reform, the New York Times reports. Report

> What if you threw a personalized medicine party and lots of people got lost along the way? Apparently, that's what's happening with Roche's breast cancer drug Herceptin. Report

> It's back to the drawing board for Johnson & Johnson and Elan. In the wake of a judge's ruling in favor of Elan's Tysabri partner Biogen Idec, J&J is lobbying for a lower price for their $1.5 billion deal, Reuters reports. Report

> U.S. District Judge John Keenan followed through on his wordFriday and declared a mistrial in the bellwether case against Merck over the drugmaker's osteoporosis drug Fosamax. Report

Biotech IT News

> Virtify has unveiled a software-as-a-service solution for managing clinical trial disclosure requirements. The Virtx CTRR Clinical Trial Registry & Results solution automates compliance with global regulatory mandates, according to an announcement. Article

> The European Bioinformatics Institute recently got a big data storage boost--$16.6 million worth--from the British Biotechnology and Biological Sciences Research Council. Article

> An attempt to simplify complex discovery software has gone beyond simplification to researcher social networking. Article

And Finally... Scientists say the tiger is brainier than the lion. Release

Suggested Articles

Inovio CEO J. Joseph Kim is undeterred by short sellers and other detractors who doubt his company can shuttle a COVID-19 DNA vaccine to market.

Adding entinostat to hormone therapy did not help patients with HR-positive, HER2-negative breast cancer live longer.

The data add to the evidence in support of the IL-6 drug ahead of a FDA decision to approve it in a rare disease served by Alexion’s Soliris.